Lathyrol Exerts Anti-Pulmonary Fibrosis Effects by Activating PPARγ to Inhibit the TGF-β/Smad Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010387 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Qian Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya Nursing School, Central South University, 172 Tongzipo Road, Changsha 410013, China. Hauptthemen laut MEDLINE: PPAR gamma, Signal Transduction, Transforming Growth Factor beta, Pulmonary Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate Student Research and Innovation Program of Central South University, Natural Science Foundation of Ningxia, National Natural Science Foundation of China.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis is a chronic, progressive, interstitial lung disease for which specific and effective drug therapies are still lacking. Lathyrol is a diterpene compound with broad pharmacological activities that can be extracted from the traditional Chinese medicine Leptochloa chinensis (L.) Nees. To investigate the anti-pulmonary fibrosis effect of lathyrol and its underlying mechanism. In vivo, a mouse model of pulmonary fibrosis was induced by bleomycin, treated with intraperitoneal injections of lathyrol. In vitro, myofibroblast conversion was induced in three fibroblast cell lines by stimulating them with TGF-β1, followed by treatment with lathyrol. Transcriptomic analysis was performed to assess the regulation of signaling pathways and gene expression patterns modulated by lathyrol. The effects of lathyrol on PPARγ activation, as well as on the nuclear translocation and ubiquitination of phosphorylated Smad3, were examined. The interaction among Nedd4, PPARγ, and phosphorylated Smad3 was detected. In vivo, lathyrol ameliorated pathological fibrosis in the lungs of mice with pulmonary fibrosis and this effect was blocked by a PPARγ inhibitor. In vitro, lathyrol inhibited the transdifferentiation of fibroblasts into myofibroblasts, and these effects were suppressed by either inhibiting PPARγ activation or specifically silencing the PPARγ gene. Lathyrol inhibited the nuclear translocation of phosphorylated Smad3 and promoted its ubiquitination, while also enhancing the interaction among Nedd4, PPARγ, and phosphorylated Smad3. These effects were abolished following the specific silencing of either PPARγ or Nedd4. In conclusion, Lathyrol inhibits myofibroblast transformation by suppressing TGF-β/Smad pathway activation through PPARγ activation, thereby exerting its anti-pulmonary fibrosis effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya Nursing School, Central South University, 172 Tongzipo Road, Changsha 410013, China.
- School of Nursing, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750003, China.
ORCID-Profile: Chong-Mei Huang, Wei Liu
Förderung
- Graduate Student Research and Innovation Program of Central South University
- Natural Science Foundation of Ningxia
- National Natural Science Foundation of China
- Hunan Provincial Graduate Student Research Innovation Project
Zitieren
APA
Zeng, Q., Liao, M. L., Luo, Y. Y., Li, S., You, G., Huang, C. M., Liu, M. H., Liu, W., & Tang, S. Y. (2025). Lathyrol Exerts Anti-Pulmonary Fibrosis Effects by Activating PPARγ to Inhibit the TGF-β/Smad Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010387
Vancouver
Zeng Q, Liao ML, Luo YY, Li S, You G, Huang CM, et al. Lathyrol Exerts Anti-Pulmonary Fibrosis Effects by Activating PPARγ to Inhibit the TGF-β/Smad Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010387
BibTeX
@article{Zeng2025,
author = {Zeng, Qian and Liao, Min-Lin and Luo, Yu-Yang and Li, Shuang and You, Gao and Huang, Chong-Mei and Liu, Min-Hui and Liu, Wei and Tang, Si-Yuan},
title = {Lathyrol Exerts Anti-Pulmonary Fibrosis Effects by Activating PPARγ to Inhibit the TGF-β/Smad Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010387}
}
EUVIMED